Ben Teh
@benwteh
Followers
424
Following
1K
Media
42
Statuses
410
ID physician & clinician researcher @NCICancer @PeterMacCC. #infection #immuneprofiling #myeloma #vaccination
Melbourne, Victoria
Joined April 2017
RT @TransplantIDNet: Optimal vaccination is challenging - especially in ICH pts!. New @NEJM @victoriahall26 study assessing flu vax in heme….
0
7
0
RT @victoriahall26: Very proud of this hard work by all involved. Limited benefit of adjuvanted flu vaccine vs standard dose and 2 vs 1 dos….
0
5
0
RT @victoriahall26: Poster presentations in session… presenting influenza-specific B & T cell analyses in pts w/ haematological malignancy….
0
5
0
Delighted to be part of @NCICancer @monicaslavin CRE to reduce the burden of infection in patients on new gen therapies.
Congratulations to the 20 new NHMRC’s Centres of Research Excellence that will share in an investment of $60 million announced today. Read our media release on our News Centre:
0
0
9
RT @PeterMacCC: Peter Mac has been awarded 3 significant @nhmrc grants totalling $9m to drive forward innovative approaches in #cancer tre….
0
3
0
Wonderful work by @GemmaKReynolds queen of systematic rev and meta-analysis!.
Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis.#clinicaltrialsandobservations #lymphoidneoplasia.
0
0
11
A global call to encourage the use of standard reporting of infection AEs so we can advance research in the field. It was also mentioned at #ESCMIDGlobal2024.
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients [Sep 6, 2023] @benwteh et al. @TheLancetInfDis #IDonc #leusm #lymsm #mmsm #mpnsm #caxtx
0
3
13
RT @mtmdphd: Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis [Oct 10, 2023] @GemmaKReynolds et….
0
1
0
RT @michyong2: #ECCMID2024 Hot topic 🔥 of developing AI tools for infection detection. Anna Khanina @NCICancer @NCAS_Aus explaining the lab….
0
8
0
RT @michyong2: #ECCMID2024 Results from RCT of SD vs AD flu vaccine as a strategy for high-risk HM group by @victoriahall26 @NCICancer @ben….
0
3
0
Hot off the press - late breaking data from @victoriahall26 @NCICancer demonstrating similiar immunogenicity from two different vax strategies and no incremental benefit of second dose. #ESCMIDGlobal2024 #TxID
1
3
14
An amazing nation wide randomised trial of a simple reminder transforming vaccination uptake, even in immune compromised. Elegant solution. #ESCMIDGlobal2024 #TxID
1
2
9
Thanks for coming to our session. @NATBASH15 and i had fun with our talks. Hope it was useful! #ESCMIDGlobal2024 #TxID
0
0
14
Superb and hard work from @victoriahall26 PhD extraordinaire. Another impactful collab with @kedzierskalab . Will guide future long acting MoAb Prep practice. #TxID.
Evolution of humoral and cellular immunity post breakthrough COVID-19 in vaccinated patients with hematologic malignancy receiving tixagevimab-cilgavimab. ✅ Just Accepted.🔓 Open Access.🔗 @victoriahall26 @benwteh @monicaslavin @kedzierskalab @ncicancer
0
3
12
Great work by @victoriahall26 and @NCICancer team. This suggests we can refine our autoHCT vax schedules #TxID.
High rates of seroprotection and seroconversion to vaccine preventable infections in the early post autologous stem cell transplant period. ✅ Just Accepted.🔓 Open Access.🔗 #OFIDEditorsChoice
1
2
11
RT @Eddie_Cliff: In light of updated MajesTEC-1 data at #IMS23 this week showing infection-related mortality of 12.7%(!), it is timely to s….
0
8
0
RT @NCICancer: .🔥 New article from @GemmaKReynolds @BeaCereus @monicaslavin @benwteh . Systematic review and meta-a….
0
10
0